McKesson to Showcase Clinical Expertise and Technology Solutions at ASHP Midyear Clinical Meeting 2017
ASHP Posters and McKesson RxO Consulting Team Demonstrate How to Achieve
Impact that Counts
Related Biotechnology, Pharmaceutical and Healthcare News
McKesson
will showcase its clinical expertise and comprehensive suite of
technology solutions designed to help hospital and health system
pharmacy leaders track, manage and grow pharmacy operations to achieve
meaningful impact for patients, the pharmacy, and their health system,
at the American Society of Health-System Pharmacists (ASHP) Midyear
Clinical Meeting 2017, which runs from Dec. 3 – 7, 2017.
“This year at ASHP, McKesson RxO is focused on delivering the expertise
and technology solutions that help health system pharmacies to achieve
impact that counts,” said Mark Eastham, B.S., R.Ph., senior vice
president and general manager, McKesson RxO. “Through one-on-one
consultations with pharmacy experts and technology demos, McKesson will
offer actionable insights that enable pharmacies to track drug spend and
increase control over their bottom line, manage operational efficiency
and the quality of care, and grow through the discovery of new revenue
opportunities.”
McKesson Booth – Technology Solution Demonstrations
Visitors to McKesson Booth #1241 will have the opportunity to engage in
one-on-one conversations with McKesson
RxO advisors and get firsthand demonstrations of new technology
solutions designed to address top pharmacy challenges:
-
McKesson RxOTMhelps health systems improve
financial and operational outcomes through its evidence-based
programs, products and services including pharmacy revenue cycle
analysis and support, and indigent drug recovery solutions. McKesson
RxO will also provide an early look at its Utilization AnalyticsTM
solution that brings together disparate data within the health system
across patient accounting, clinical, pharmacy, and reimbursement to
one source to drive meaningful insights. In addition, McKesson’s
supply chain management solutions such as its competitive generics
portfolio, lean Six Sigma methodologies and training, timely drug
shortage information, and single-source access to specialty products
helps customers increase efficiency and deliver measurable,
time-saving results. McKesson provides actionable pharmacy insights
through detailed drug spend analytics, 340B program management,
improved billing accuracy and more.
-
McKesson High Volume Solutions is featuring its new Central
Fill as a Service (CFaaS) product, which is a first-of-its-kind
solution that allows outpatient pharmacies to realize the benefits of
central fill for a small per script fee that is lower than their
current cost to fill. McKesson focuses on its area of expertise,
dispensing and distribution, allowing the pharmacy to focus on patient
care. McKesson owns and operates the equipment and inventory, only
billing the pharmacy when the prescription is actually dispensed.
Partnering with McKesson allows health systems to realize the benefits
of central fill without the associated equipment and inventory
carrying costs while maintaining control of their pharmacy license,
staff and patients.
-
Macro Helix is featuring its latest solution, NDC ArchitectSM,
which was built to simplify and automate the billing process for
carving-in Medicaid. It is a sophisticated claims-editing solution
that can help improve charge accuracy to save time and money. The
user-friendly tool collects and analyzes data from hospital patient
visits and updates billing system records to ensure that each bill
accurately reflects the specific drugs administered. Evaluating and
updating claims at the individual charge level helps to maximize both
reimbursement and 340B savings.
-
McKesson Pharmacy Systems (MPS) will be providing live demos of
the EnterpriseRx® pharmacy management system and its
integrated Adherence Performance Solution and Clinical Programs
SolutionTM modules. The centralized pharmacy management
system can help simplify workflow, increase prescription volume
capacity, integrate with central fill operations, manage resources and
information centrally, in real time, for system-wide access and
monitoring and results in reduced DIR fees, providing enhanced patient
experience.
-
Supplylogixwill be demonstrating its Pinpoint®
suite of intelligence solutions. A highly scalable web services
platform, the Pinpoint suite of technology products enable pharmacies
to gain a competitive advantage through streamlined visibility and
thoughtful asset management. These software as a service tools provide
key insights and drive decision making throughout every stage of the
inventory lifecycle. Compliance features assess risk and help to
identify theft while easily monitoring controlled substances across an
organization.
-
McKesson’s automation partner, Parata, will demonstrate its
vial and pouch packaging solutions. Parata automation allows health
system pharmacists to free up labor for other value-added activities
such as medication reconciliation consulting, patient education, and
post-discharge interventions to improve patient outcomes. Parata Max®
and Parata Mini® robotic vial dispensing technologies fill
scripts safely, prevent controlled-substance diversion, manage an
increasing script volume, and store, monitor and track drugs safely
and securely. The Parata PASS 208® pouch packager organizes
medications the way patients take them, by day and time of dose. The
Parata Perl™ Pouch Inspector automates and accelerates
pouch verification with speed and accuracy rates the industry has
never seen before. Parata’s pouch packaging solutions empower
pharmacists to take a more proactive role in patient outcomes, avoid
readmission for discharged patients, support common “med to bed”
health system programs, and provide services to other health system
entities such as a hospice or care center.
-
A McKesson Ventures-backed portfolio company – PipelineRx –
will feature its newest solution for discharge management. Leveraging
the company’s PowerGridRx™ cloud-based pharmacy platform, hospitals
and health systems can deliver clinical pharmacist expertise to
patients and their caregivers at the time of discharge. This solution
is designed to improve outcomes, reduce readmissions, and increase
patient satisfaction by enhancing communication and workflow for
medication adherence after discharge. By focusing on eight diagnoses
identified by the Centers for Medicare and Medicaid Services for
readmission penalties or by using the LACE Index scoring tool,
hospitals can target those patients at highest risk of readmission and
support better outcomes through the appropriate use of medications
after the patient has returned home.
ASHP Poster Sessions to Feature McKesson Solutions
ASHP will feature a number of McKesson customers and solutions in poster
sessions covering the following topics:
-
“The revision of inpatient antineoplastic infusion admission
guidelines for cost containment,” Monday, Dec. 4 from 2:30 – 4:30
p.m.
-
“Pharmacy financial reporting package: budget variance evaluation
and identification of expense mitigation initiatives,” Monday,
Dec. 4 from 2:30 – 4:30 p.m.
-
“Pharmacist managed anemia clinic improves guideline adherence for
darbepoetin,” Tuesday, Dec. 5 from 2:30 – 4 p.m.
About McKesson Corporation
McKesson Corporation, currently ranked 5th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company” in the healthcare wholesaler category by FORTUNE, a
“Best
Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly
company by Military Friendly. For more information, visit mckesson.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171201005539/en/
McKesson U.S. Pharmaceutical
Kristen Kouk, 972-446-5788
kristen.kouk@mckesson.com
NEXT ARTICLE
More From BioPortfolio on "McKesson to Showcase Clinical Expertise and Technology Solutions at ASHP Midyear Clinical Meeting 2017"